Complix | Sliders Homepage 01

Home
Our company
Our technology
Pipeline
News
Careers
Partnering
Contact us

Home
Our company
Our technology
Pipeline
News
Careers
Partnering
Contact us

No posts were found.

About Complix

Complix is a biopharmaceutical company developing a pipeline of transformative Cell Penetrating Alphabody (CPAB) based biotherapeutics active against cutting-edge and challenging intracellular targets that play a key role in life threatening diseases, including cancer.

Recent news

Complix Signs Global Drug Discovery and Development Agreement with Jiangsu Nhwa Pharmaceutical Co. to Develop Novel Alphabody Therapeutics for Treatment of CNS Diseases July 28, 2021
Complix and VIB Publish Pioneering Study on Cell-Penetrating Alphabodies in Science Advances March 31, 2021
Complix Signs Global Drug Discovery and Development Agreement with I-Mab to Develop Cell Penetrating Alphabodies against Two Intracellular Immuno-oncology Targets March 10, 2021

Complix newsletter

Subscribe to the Complix newsletter & stay up to date with news, events & projects.

Contact us

Technologiepark 94
9052 Zwijnaarde (Ghent)
Belgium
Phone: +32 (0)9 261 69 40
Fax: +32 (0)9 261 69 50
E-Mail: info@complix.com